1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Muckle-Wells Syndrome Global Clinical Trials Review, H1, 2014

Muckle-Wells Syndrome Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Muckle-Wells Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Muckle-Wells Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Muckle-Wells Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Muckle-Wells Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Muckle-Wells Syndrome Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Muckle-Wells Syndrome 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Muckle-Wells Syndrome to Dermatology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Muckle-Wells Syndrome to Dermatology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Muckle-Wells Syndrome 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Muckle-Wells Syndrome Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Novartis AG 28
Clinical Trial Overview of Novartis AG 28
Regeneron Pharmaceuticals, Inc. 29
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 29
Clinical Trial Overview of Top Institutes / Government 30
Istituto Giannina Gaslini 30
Clinical Trial Overview of Istituto Giannina Gaslini 30
Charite - Universitatsmedizin Berlin 31
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 31
National Institute of Arthritis and Musculoskeletal and Skin Diseases 32
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 32
Five Key Clinical Profiles 33
Appendix 124
Abbreviations 124
Definitions 124
Research Methodology 125
Secondary Research 125
About GlobalData 126
Contact Us 126
Disclaimer 126
Source 127

List of Tables
Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Region, 2014* 6
Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Muckle-Wells Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Muckle-Wells Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Muckle-Wells Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Muckle-Wells Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Muckle-Wells Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Muckle-Wells Syndrome to Dermatology Clinical Trials, G7 Countries (%), 2014* 14
Muckle-Wells Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Muckle-Wells Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Muckle-Wells Syndrome to Dermatology Clinical Trials, E7 Countries (%), 2014* 17
Muckle-Wells Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Muckle-Wells Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2014* 22
Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Muckle-Wells Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Muckle-Wells Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 28
Muckle-Wells Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2014* 29
Muckle-Wells Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Giannina Gaslini, 2014* 30
Muckle-Wells Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014* 31
Muckle-Wells Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 32

List of Figures
Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Muckle-Wells Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Muckle-Wells Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Muckle-Wells Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Muckle-Wells Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Muckle-Wells Syndrome to Dermatology Clinical Trials, G7 Countries (%), 2014* 14
Muckle-Wells Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Muckle-Wells Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Muckle-Wells Syndrome to Dermatology Clinical Trials, E7 Countries (%), 2014* 17
Muckle-Wells Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Muckle-Wells Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
GlobalData Methodology 125

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.